2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Selected funding rounds

Date Company Profile Round Ccy Amount
Feb 2011 Chimerix Inc Series F
Feb 2011 Chimerix Inc Series F
Feb 2011 Chimerix Inc Series F
7 Jan 2011 23andMe Inc DNA testing and genome sequencing firm. Series C USD 9,000,000
Jan 2011 Acadia Pharmaceuticals Inc Small molecule drug discovery and development company. N/A
2011 ADVANCE Medical Inc N/A
Jan 2011 SurePoint Medical LLC Provider of medical and diabetic testing supplies. N/A
Jan 2011 Acylin Therapeutics Inc Series A
2011 Kunming Jida Pharmaceutical Domestic branded generic drug provider N/A
2011 Tangent Medical Technologies Inc N/A
2011 Biofilm Ltd N/A
9 Nov 2010 23andMe Inc DNA testing and genome sequencing firm. Series C USD 22,000,000
Nov 2010 Delenex Therapeutics AG Series A
Nov 2010 Virtual Incision Corp Series A
Nov 2010 Delenex Therapeutics AG Series A
Nov 2010 Delenex Therapeutics AG Series A
5 Oct 2010 Celon Labs Oncology pharmaceutical products N/A
Oct 2010 Essentialis Inc Developing a novel therapy for the treatment of dyslipidemia. Series B
Oct 2010 Auspex Pharmaceuticals Series C
Oct 2010 Auspex Pharmaceuticals Series C

Pages

Selected companies

Company type: 
Personalized medicine company specializing in pharmacogenetics
Company type: 
Switzerland-based drug company focused on CNS disorders
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products